Asker Healthcare Group acquires Aspironix

News

Share

Nalka portfolio company Asker Healthcare Group has acquired 100 percent of the shares in Aspironix, a distributor of medical devices to hospitals, pharmacies and general practitioners, based in the Czech Republic.





“Aspironix has built a strong position as a specialist supplier to the hospitals in key markets of Central Europe and we are pleased the founder has chosen Asker as the company’s partner in its continued growth. Aspironix creates a solid platform for further growth in the region and in Asker’s ambition to be the leading healthcare group in Europe within medical products and solutions – driving progress in the healthcare sector”, says Johan Falk, CEO of Asker Healthcare Group.

The company has 70 employees and a revenue of approximately SEK 200m per year.

Read more:

Share

More news

News

Asker Healthcare Group strengthens position in the Netherlands

News

Asker Healthcare Group completes 50th acquisition since 2019

News

Cibes Lift Group expands to New York and Pennsylvania with new acquisition